baber/WOPTO huggingface dataset:
Patent AU-2020242080-A1 (AU)
Title: A mould assembly for a skimmer box lid
Inventor: FREEMAN WILLIAM GEOFFREY
IPC: B29C33/12
Filed: 2020-03-20
Abstract: A mould assembly for a skimmer box lid includes a mould including a floor and a sidewall extending from the floor, the floor and sidewall defining a mould cavity into which a settable material can be introduced. The floor defines at least one aperture. The assembly includes at least one mould insert having a tubular body that is configured for attachment to the floor to extend from the floor to a height that is at least substantially equivalent to a height of the sidewall, the tubular body defining an elongate passage to be in register with a respective aperture such that, when the settable material is introduced into the mould cavity and subsequently sets, the mould body, the, or each, mould insert, and the settable material form the skimmer box lid with the, or each, passage extending through the skimmer box lid so that a suitable tool can be used to lift the skimmer box lid.
Patent AU-2020272506-A1 (AU)
Title: Control channel monitoring capability for low latency communications
Inventor: HOSSEINI SEYEDKIANOUSH
IPC: H04L5/00
Filed: 2020-03-02
Abstract: This disclosure provides systems, methods and apparatus where a user equipment (UE) may indicate different physical downlink control channel (PDCCH) monitoring capabilities (such as UE capabilities in terms of the number of control channel elements (CCEs), blind decodes (BDs), number of downlink control information (DCI) formats, etc.) per monitoring span or slot. For example, a UE may support a different number of CCEs per slot or a different number of DCIs per monitoring span for different service types (such as a different number of CCEs for enhanced mobile broadband (eMBB) and for ultra-reliable low latency communications (URLLC)). A UE may indicate different sets of PDCCH monitoring capabilities (such as sets of PDCCH monitoring capabilities for different service types, monitoring spans, slots, etc.). A base station may receive the indication of UE PDCCH monitoring capability information, and may configure the UE with one or more monitoring occasions accordingly.
Patent AU-2020272936-A1 (AU)
Title: Methods and systems for crack detection using a fully convolutional network
Inventor: CHEN FU-CHEN
IPC: G06N3/08
Filed: 2020-04-09
Abstract: Systems and methods for detecting cracks in a surface by analyzing a video, including an full-HD video, of the surface. The video contains successive frames, wherein individual frames of overlapping consecutive pairs of the successive frames have overlapping areas and a crack that appears in a first individual frame of a consecutive pair of the successive frames also appears in at least a second individual frame of the consecutive pair. A fully convolutional network (FCN) architecture implemented on a processing device is then used to analyze at least some of the individual frames of the video to generate crack score maps for the individual frames, and a parametric data fusion scheme implemented on a processing device is used to fuse crack scores of the crack score maps of the individual frames to identify cracks in the individual frames.
Patent AU-2020273158-A1 (AU)
Title: Dosage forms and regimens for amino acid compounds
Inventor: CHA JACOB
IPC: A61K31/00
Filed: 2020-04-08
Abstract: The invention relates to dosage forms for daily administration of compounds of formula (A) and formula (I): or a salt thereof, wherein R
Patent AU-2020277212-A1 (AU)
Title: Tomato variety NUN 09271 TOF
Inventor: SILVERTAND BEN
IPC: A01H6/82
Filed: 2020-11-26
Abstract: The disclosure provides a hybrid tomato variety NUN 09271 TOF as well as seeds and plants 
and fruits thereof. NUN 09271 TOF is a cherry round, cluster tomato variety for the fresh 
market comprising resistance to Meloidogyne incognita, Tomato Mosaic Virus (ToMV) Strain 
0, Strain 1, Strain 2, and Strain 1-2, Fusarium oxysporum f. sp. lycopersici Race 0 and Race 1, 
Fusarium oxysporum f. sp. radicis lycopersici Race 0, Fulviafulva Groups A-E, and Oidium 
lypersicum.  
52
1/4 
Fig. 1
Patent AU-2020311022-A1 (AU)
Title: Bracket for use with open display refrigerators
Inventor: MCANDREW PAUL
IPC: A47F3/04
Filed: 2020-07-01
Abstract: A bracket for attaching an air curtain guide to a refrigerator she!f, the bracket comprising: a first end having a surface for engagement with an edge of a refrigerator shelf; a second end for coupling to an air curtain guide; wherein the first end is connected to the second end by a continuous member, such that the first end is offset from the second end in a first direction.
Patent AU-2020311441-A1 (AU)
Title: Multi-agent ocular formulations and treatment methods
Inventor: BURR RANDON MICHAEL
IPC: A61P27/02
Filed: 2020-07-13
Abstract: Opthalmic compositions are disclosed and described herein. In some embodiments, an ophthalmic composition can include as active agents a copper-containing agent and a secondary therapeutic agent in combination with a pharmaceutically acceptable carrier. The active agents can be present in amounts sufficient to treat myopic progression during a treatment period.
Patent AU-2020410192-A1 (AU)
Title: Improved turret mooring system
Inventor: HAYMAN JASON
IPC: B63B21/50
Filed: 2020-12-18
Abstract: Disclosed herein is a turret mooring system for a tidal turbine assembly 150, which increases the ratio of the torque exerted by the turret 100 relative to frictional forces between the turret 100 and the assembly 150 moored to the turret 100. In some examples, the frictional forces are reduced by the turret providing an upward force to the assembly, which also resists pitching moments. In other examples, the torque exerted by the turret 100 is increased by the use of a bifurcated mooring line 106, 108 which couples to two spaced apart attachment points 128 on a chain table 104 of the turret 100 and to a single point 114 on the water bed.
Patent WO-2022016216-A1 (WO)
Title: Biocompatible polymer compositions
Inventor: SHIROUD HEIDARI BEHZAD
IPC: A61L27/26
Filed: 2021-07-20
Abstract: Biocompatible polymer compositions suitable for biomedical applications, wherein the polymer compositions are biodegradable and wherein the polymer compositions comprise, PDO droplets dispersed within an LCL matrix.
Patent AU-2021204072-A1 (AU)
Title: An air diffusion system
Inventor: TITCHKOSKY NINOTSCHKA ANNA
IPC: G06F30/20
Filed: 2021-06-18
Abstract: The present invention relates to an air-diffusion system, a computer-implemented 
method of designing an air-diffusion system, an apparatus for additive manufacturing 
an air-diffusion system, and a method of additive manufacturing an air-diffusion 
5 system.
Patent AU-2021204452-A1 (AU)
Title: Equipment and method for automatically wrapping a film around an object
Inventor: BRUNI VALERIANO
IPC: B65B11/04
Filed: 2021-06-29
Abstract: The present invention refers to an equipment and a method for wrapping a film around an object 
placed on a pallet.  
The equipment includes: a) a reel-holder carriage equipped with an outlet designed to allow 
the film to come out of the carriage through it; and b) at least one device suitable for blowing 
air, placed at the outlet and integral with the carriage, which allows the end strip of the film, 
once it has come out of the carriage, to spread slowly, without any tension, on the ground 
around the base of the object to be wrapped.  
The rotation around the object to be wrapped of a movable body forming part of the equipment 
of the present invention, or, alternatively, the rotation on itself of the object to be wound in 
proximity to the equipment, allows tensioning of the strip of the film and the subsequent 
superimposition on it of a portion of the film that gradually emerges from the carriage during 
rotation, so as to fix the film to the object to be wrapped.
7/10 
|| 
I 4 
10 2 
8 
6 
1 7 69 
3 15 
Figure 4a
Patent AU-2021212627-A1 (AU)
Title: Use of 5-amino-2,3-dihydro-1,4-phthalazinedione in the inhalatory treatment of inflammatory pulmonary diseases
Inventor: BRYSCH WOLFGANG
IPC: A61K9/00
Filed: 2021-01-29
Abstract: The present invention relates to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione or its pharmaceutically acceptable salts in the inhalatory treatment of inflammatory pulmonary diseases. The invention in particular relates to the use of 5-amino-2,3-dihydro-1,4-phthalazinedione sodium salt for said purposes. Advantageous features of an aerosol containing 5-amino-2,3-dihydro-1,4-phthalazinedione or its pharmaceutically acceptable salts and a method for producing said aerosol are disclosed. The present invention further relates to a kit for inhalatory treatment of inflammatory pulmonary diseases.
Patent AU-2021212741-A1 (AU)
Title: Structural optimization method to improve the theranostic performance of peptide receptor-targeted radionuclide therapy for cancers
Inventor: Lee Dongyoul
IPC: A61K51/04
Filed: 2021-01-28
Abstract: The present invention provides in certain embodiments a carcinoma-targeting conjugate comprising Formula I wherein T is a SST2R targeting ligand, L is a linker, and X is a chelator, for the therapeutic treatment of cancer, and methods of use thereof.
Patent AU-2021215709-A1 (AU)
Title: 3-pyrrolidine-indole derivatives as serotonergic psychedelic agents for the treatment of CNS disorders
Inventor: SLASSI ABDELMALIK
IPC: C07D403/06
Filed: 2021-02-04
Abstract: The present application relates to 3-cyclic amine-indole derivatives of general Formula (I), to processes for their preparation, to compositions comprising them and to their use in activation of a serotonin receptor in a cell, as well as to treating diseases, disorders or conditions by activation of a serotonin receptor in a cell. The diseases, disorders or conditions include, for example, psychosis, mental illnesses, and other neurological diseases, disorders and conditions. Formula (I)
Patent AU-2021217799-A1 (AU)
Title: Process for making adenoassociated viral vectors
Inventor: CAWOOD RYAN
IPC: C12N15/86
Filed: 2021-02-03
Abstract: The invention relates to a nucleic acid molecule encoding at least one AAV Rep polypeptide, wherein one or more of the AAV (p5), (p19) and (p40) promoters have been modified to reduce or eliminate expression of one or more of the Rep polypeptides, or the nucleic acid molecule does not encode functional (Rep52) or (Rep40) polypeptides, or the nucleic acid molecule does not encode a functional adenovirus inhibitor sequence. The invention also relates to a process for producing recombinant AAV vectors through the use of a 2-adenovirus system, wherein all of the genes required for AAV replication and packaging (i.e. an AAV rep sequence of the invention, AAV cap and the AAV transfer vector comprising a transgene) may be encoded within two adenoviruses.
Patent AU-2021221845-A1 (AU)
Title: Sanitising Systems and Methods
Inventor: LITERSKI GEOFF
IPC: A01N37/02
Filed: 2021-08-25
Abstract: A method of cleaning or sanitising a material, the method including the steps of 
spraying the material with a sanitising liquid as it travels along a conveyor path and/or 
falls therefrom using one or more liquid spraying devices.
Patent AU-2021231230-A1 (AU)
Title: Automated storage systems, and devices
Inventor: JOHANNISSON WILHELM
IPC: B65G1/04
Filed: 2021-03-03
Abstract: A drive belt assembly for a load handling device is provided, the drive belt assembly comprising: a drive belt; a drive wheel; one or more driven wheels; a tensioning means comprising: a first tensioning arm having a fixed end above an elbow and a rotatable distal end pivotally attached at the elbow, wherein the first tensioning arm is horizontally displaceable relative to the drive wheel and driven wheels; and a second tensioning arm, wherein the drive belt is routed around the first and second tensioning arms and the first and second tensioning arms are arranged to put pressure on the drive belt to tension the drive belt.
Patent AU-2021235877-A1 (AU)
Title: Matrix and associated sample or mixing cup used for removing components of a liquid sample
Inventor: FALLER JESSE DANIEL
IPC: A61J7/00
Filed: 2021-03-08
Abstract: An insert mounted in a mixing cup and used by an automated chemical analyzer for removing a targeted component of a liquid sample includes a porous matrix formed of or carrying in an immobilized state functionalized particles having properties such that the targeted component of the liquid sample adheres to the functionalized particles. When the liquid sample is expelled from a disposable tip fitted on the end of a pipette forming part of the automated chemical analyzer into the mixing cup, the liquid sample is drawn into the matrix of the insert by capillary action, whereupon the targeted component of the liquid sample adheres to the immobilized functionalized particles of the matrix.
Patent AU-2021240214-A1 (AU)
Title: Elbow joint prostheses
Inventor: Kartholl Matthew Victor
IPC: A61F2/46
Filed: 2021-09-29
Abstract: A radial head assembly (100) is provided that includes a stem (124), a collar (108), a locking ring (I 
12), and an articular member (I16). The stem has a convex articular head on one end thereof. The 
locking ring has a ring wall (220), which has a ring opening (224). The ring wall has an angular outer 
surface (228) and a slot (232) configured to permit the ring wall to radially expand. The angular outer 
surface engages an angular portion of an interior surface (172) of the collar. The articular member 
and the locking ring define an articular space (120) within the collar. The articular space is configured 
to receive the convex articular head.
Patent AU-2021260192-A1 (AU)
Title: Body-protector
Inventor: LLOYD JOHN GEORGE
IPC: A63B71/14
Filed: 2021-04-23
Abstract: Body-protector (1,1') comprising: a wearable article (2,2'); a shock-absorbing pad (3) anchored to the wearable article (2,2'); wherein the shock-absorbing pad (3) comprises a first member (4) configured to absorb shock energy by an irreversible plastic deformation and a second member (5) configured to absorb shock energy by a reversible elastic deformation and wherein the first member (4) is embedded in the second member (5); wherein the first member (4) comprises a plurality of cells (6) interconnected each other via their sidewalls (7) to form a pliable sheet (8) configured to absorb energy through irreversible deformation of said sidewalls (7) or said interconnections in response to a compressive load applied to said sheet (8). Said wearable article (2) being a glove (2') wherein said shock-absorbing pad (3) is anchored to a back of the glove (2').
Patent AU-2021263590-A1 (AU)
Title: Nucleic acids and methods of treatment for cystic fibrosis
Inventor: PEREZ-GARCIA CARLOS G
IPC: C07K14/47
Filed: 2021-04-30
Abstract: Nucleotides encoding a Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) protein are provided herein. Also describe are mRNA constructs that can be used to express CFTR protein
Patent AU-2021265805-A1 (AU)
Title: Marine fishery trap baits and deterrents
Inventor: SAVAGE ALAN
IPC: A01M23/00
Filed: 2021-04-29
Abstract: Processes for encapsulating bio-affecting compositions comprising attractants, deterrents, and/or nutrients for inclusion in calcium sulphate blocks to reduce the rate of block degradation during storage or when placed in water when used as trap baits and deterrents for attracting, deterring and/or feeding aquatic species, particularly during fishing for decapod crustaceans.
Patent AU-2021269396-A1 (AU)
Title: Very-long-chain polyunsaturated fatty acids, elovanoid hydroxylated derivatives, and methods of use
Inventor: BAZAN NICOLAS G
IPC: C07C57/03
Filed: 2021-11-18
Abstract: Provided are compounds, pharmaceutical compositions, cosmetic and dermatological compositions or 
nutritional supplement compositions, comprising omega-3 very-long-chain polyunsaturated fatty acids 
(n-3 VLC-PUFAs) and/or their endogenous hydroxylated derivatives thereof, known as elovanoids.  
This disclosure provides methods for neuroprotection, organ and tissue protection or restoration, 
prevention or slowing down of aging-related diseases and conditions, and sustainment of function 
during the aging process.  
Phophatidyl choline 
Molecular species 
1=S, C34:6n 
n3 VLC-PUFA BHA (C22:n3) 
LOV VLC-PUFA 
DHA 
----- M I C22:OW 2 
1 C226G3 
L )LOX 
Dihydroxy Monohydroxy 
Elovanoids Elovanoids 
mt=8, ELV N32, C32:n3 NO m=S, ELV-278, C32:n3 
mi10, ELV-N34, C34:6B3 5 Fig. 14 m:1, Etv-2s, Ca4:n
Patent AU-2021274979-A1 (AU)
Title: Intraoperative imaging and virtual modeling methods, systems, and instrumentalities for fracture reduction
Inventor: CAMPBELL CHRISTOPHER
IPC: G06T19/20
Filed: 2021-05-20
Abstract: A method of evaluating a bone fracture reduction includes imaging, intraoperatively, a fractured bone to obtain a representation of the fractured bone in a computing system. The fractured bone defines at least first and second bone fragments separated by a fracture. The method includes imaging a contralateral bone of the patient to obtain a representation of the contralateral bone in the computing system and further includes generating, intraoperatively in the computing system, a virtual model of the fractured bone from data presented in the representation of the fractured bone and a virtual model of the contralateral bone from data presented in the representation of the contralateral bone. The method includes comparing, intraoperatively in the computing system, a spatial dimension measured with respect to the virtual model of the fractured bone with a corresponding spatial dimension measured with respect to the virtual model of the contralateral bone.
Patent AU-2021277590-A1 (AU)
Title: Compositions and methods relating to a mutant clostridium difficile toxin
Inventor: JANSEN KATHRIN UTE
IPC: C07K14/33
Filed: 2021-11-29
Abstract: COMPOSITIONS AND METHODS RELATING TO A MUTANT CLOSTRIDIUM 
DIFFICILE TOXIN 
Abstract 
The invention relates to an immunogenic composition that includes a mutant Clostridium 
difficile toxin A and/or a mutant Clostridium difficile toxin B. The mutant toxin may include a 
glucosyltransferase domain having at least one mutation and a cysteine protease domain having 
at least one mutation, relative to the corresponding wild-type C. difficile toxin. The mutant toxins 
may include at least one amino acid that is chemically crosslinked. In another aspect, the 
invention relates to methods and compositions for use in culturing Clostridium difficile and in 
producing C. difficile toxins.
Patent AU-2021297308-A1 (AU)
Title: Retractable phased array for mobile devices
Inventor: WOODS JR WAYNE H
IPC: H01Q3/44
Filed: 2021-06-24
Abstract: An electronic device includes: a housing; a display; and an extendable phased array antenna structure integrated with the housing and moveable relative to the housing between a retracted position and an extended position. The extendable phased array antenna structure comprises an array of antenna elements that are configured to form a beam in a determined direction.
Patent AU-2021297323-A1 (AU)
Title: AMPK activators
Inventor: SEBHAT IYASSU
IPC: C07D405/12
Filed: 2021-06-24
Abstract: This disclosure is directed, at least in part, to AMPK activators useful for the treatment of conditions or disorders associated with AMPK. In some embodiments, the condition or disorder is associated with the gut-brain axis. In some embodiments, condition or disorder is associated with systemic infection and inflammation from having a leaky gut barrier. In some embodiments, the AMPK activators are gut-restricted compounds. In some embodiments, the AMPK activators are agonists, super agonists, full agonists, or partial agonists.
Patent AU-2021299904-A1 (AU)
Title: Amuc-1100 polypeptide variants for effecting immune signalling and/or affecting intestinal barrier function and/or modulating metabolic status
Inventor: DE VOS WILLEM MEINDERT
IPC: A61P3/08
Filed: 2021-06-21
Abstract: Polypeptide variants of an extracellular polypeptide of Akkermansia municiphila are provided which are capable of modulating and/or promoting gut mucosal immune system function and/or maintaining and/or restoring metabolic status and/or increasing the physical integrity of the gut mucosal barrier in a mammal. The polypeptide variants or host cells comprising such polypeptide variants may be employed to prevent and/or treat a variety of conditions that benefit from an increased physical integrity of the gut mucosal barrier and/or an improved gut mucosal immune system function and metabolic status.
Patent AU-2021302647-A1 (AU)
Title: Dishwasher
Inventor: CHAI BIAO
IPC: A47L15/44
Filed: 2021-06-30
Abstract: A dishwasher comprises an internal reservoir for rinse-aid or other wash or rinse additive, a door associated with a refill port to the rinse-aid reservoir, and a flexible conduit between the refill port and the rinse-aid reservoir. The door associated with the refill port to the rinse-aid reservoir may also carry or enable access to a detergent compartment.
Patent AU-2021302895-A1 (AU)
Title: Pivoting cantilever umbrella, umbrella mitigating the risks of wind damage, and angle bracket for a cantilever umbrella
Inventor: NEVIN MICHAEL PATRICK
IPC: A45B23/00
Filed: 2021-06-25
Abstract: An cantilever umbrella (100) comprises a base (102), post (101), cantilever arm (103) and a canopy (106) that is supported on a hub (104) with radial arms (105). The canopy (106) can pivot about an axis parallel to the cantilever arm (103) by pivoting the hub (104) relative to the cantilever arm. The umbrella (100) is protected against excess wind by pivoting outer parts (202) of the radial arms (105) upwards, but holding the outer parts (202) down with tension in the canopy (106) during normal use. A concealed, self-aligning angle bracket (300) is used to attach an upper end (302) of the post (101) to a proximal end (303) of the cantilever arm (103).
Patent AU-2021315452-A1 (AU)
Title: Suppression of cytokine release and cytokine storm
Inventor: SORDILLO PETER P
IPC: A61K39/00
Filed: 2021-07-13
Abstract: The present invention includes methods and compositions for ameliorating symptoms or treating one or more adverse reactions triggered by infectious diseases or disease conditions that trigger a widespread release of cytokines in a subject comprising the steps of: identifying the subject in need of amelioration of symptoms or treatment of the infectious diseases or disease conditions that trigger a widespread release of cytokines; and administering one or more pharmaceutical compositions comprising a therapeutically effective amount of a curcumin extract, curcuminoids or synthetic curcumin (S-curcumin) and derivatives thereof, and lipids dissolved or dispersed in a suitable aqueous or non-aqueous medium sufficient to reduce the level of cytokines in the host.
Patent AU-2021336779-A1 (AU)
Title: Medical device stabilizing systems
Inventor: BOWES ROBERT
IPC: A61B90/57
Filed: 2021-08-31
Abstract: Various stabilizing systems and devices are described for holding and maneuvering medical devices. Some systems and devices include one or more of a base plate, a carriage, and a clamp, or a combination thereof. The base plate can be attached to one or more tables. The carriage can be moveably attached to the base plate or can be integrally formed with the base plate. The carriage can receive one or more clamps. The one or more clamps can be moveably attached to the carriage or the base and configured to receive one or more medical devices.
Patent AU-2021367125-A1 (AU)
Title: Beverage preparation machine having a silicone drip grid
Inventor: ERDWIENS ALEXANDER
IPC: A47J31/44
Filed: 2021-10-20
Abstract: The invention relates to a beverage preparation machine (1) which comprises an outlet (14) for dispensing a prepared beverage, a receiving area (15) for receiving a vessel in which the prepared beverage is to be received, and a setting-down element (21) that delimits the receiving area (14) into the side opposite the outlet (14) and on which the vessel can be placed during the preparation of the beverage. The setting-down element (21) is at least partially made from an elastomer.